Explore the categories so you can find more about your search.
Categorie > Cholesterol
Phase III Data Published On The Effect Of 'Tredaptive' (nicotinic Acid /laropiprant) Combined With Simvastatin On LDL-C, HDL-C And Triglyceride Levels
Categorie : CholesterolResults from a phase III clinical study published in the latest issue of British Journal of Cardiology showed that patients with primary hypercholesterolaemia or mixed dyslipidaemia) when treated with 2 g 'Tredaptive' (nicotinic acid/ laropiprant) co-administered with simvastatin (pooled across 20 m ...
read more 
Wed May 2009
New Data For Abbott's TRILIPIX(R) (fenofibric Acid) In Combination With Rosuvastatin Calcium Shows Improvement On Key Lipids For Cholesterol
Categorie : CholesterolData from a new study showed that Abbott's TRILIPIX(R) (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium met all of the study's primary endpoints. TRILIPIX 135 mg in combination with rosuvastatin calcium 5 mg significantly improved HDL cholesterol and triglycerides ...
read more Wed May 2009
5 In 1 Polypill May Significantly Cut Heart Risk In Healthy People
Categorie : CholesterolA study conducted in India suggested taking a single capsule containing five drugs: a statin, aspirin and three blood pressure drugs, could significantly cut the risk of heart disease among healthy people without side effects. The phase II clinical trial was the work of principal investi ...
read more Wed May 2009
CRESTOR(R) Reduced CV Risk In Patients Achieving Low LDL-C And HsCRP Targets In New Jupiter Analysis
Categorie : CholesterolResults from a new sub-analysis of the JUPITER study show that patients who attained a dual treatment target of LDL-C ...
read more Wed May 2009
CRESTOR(R) Is The First Statin To Reduce Risk Of Blood Clots In Veins In A Large Prospective Randomised Study
Categorie : CholesterolA new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP) ...
read more Wed May 2009
Rosuvastatin (Crestor) Reduced Blood Clot Risk
Categorie : CholesterolA large trial of the cholesterol lowering drug rosuvastatin (Crestor from AstraZeneca) showed that giving it to healthy adults reduced their risk of blood clots (venous thromboembolism) by 43 per cent. ...
read more Wed May 2009
Statin Prescriptions Highlight Healthcare Inequalities, Australia
Categorie : CholesterolStatin prescription varies across geographic locations in Australia, according to a study in The Australian Journal of Rural Health by published Wiley-Blackwell. This difference in statin prescribing not only demonstrates inequalities in healthcare due to geography, it also suggests that the acc ...
read more Wed May 2009
Cholesterol Crystals Linked To Cardiovascular Attacks
Categorie : CholesterolFor the first time ever, a Michigan State University researcher has shown cholesterol crystals can disrupt plaque in a patient's cardiovascular system, causing a heart attack or stroke. The findings by a team led by George Abela, chief of the cardiology division in MSU's College of Human Med ...
read more Wed May 2009
Patients With Higher Drug Co-Payments Discouraged From Starting Treatment
Categorie : CholesterolPatients newly diagnosed with hypertension, diabetes or high cholesterol are significantly more likely to delay initiating recommended drug treatment if they face higher co-payments for medications, according to a new RAND Corporation study. The delay was significant across all conditions, but th ...
read more Wed May 2009
High Co-Payments Associated With Delay In Starting Drug Therapy In Patients With Chronic Diseases
Categorie : CholesterolHigh co-payments are associated with delayed initiation of medication in patients with newly diagnosed hypertension, diabetes and elevated cholesterol levels, according to a report in the April 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Rising prescription dru ...
read more Wed May 2009
PDAs, More Education Help Doctors Follow Cholesterol Treatment Guidelines
Categorie : CholesterolA new study by researchers at Wake Forest University School of Medicine suggests that patients with high cholesterol receive better care when physicians use a variety of tools to learn and apply a clinical practice guideline for treating the condition. The study, published in the April 13 issue o ...
read more Wed May 2009
Cholesterol Appears To Promote Tamoxifen Resistance In Some Breast Cancer Cells Say GUMC Researchers
Categorie : CholesterolBreast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC). They say their study, presented at the Annual Meeting of the Am ...
read more Wed May 2009
Atherotech To Exhibit Its VAP(R) Cholesterol Test At Internal Medicine 2009 In Philadelphia
Categorie : CholesterolAtherotech, Inc. announced it will be exhibiting its VAP(R) Cholesterol Test in booth #912 at Internal Medicine 2009, the annual scientific meeting of the American College of Physicians (ACP). The conference takes place April 23-25, 2009, at the Pennsylvania Convention Center in Philadelphia. ...
read more Wed May 2009
Where 'Bad' Cholesterol Levels Are Controlled
Categorie : CholesterolResearchers at UT Southwestern Medical Center have found that a protein responsible for regulating "bad" cholesterol in the blood works almost exclusively outside cells, providing clues for the development of therapies to block the protein's disruptive actions. "The fact that it works mostly extr ...
read more Wed May 2009
Removing The Adverse Side Effects From An Effective Drug
Categorie : CholesterolNicotinic acid is one of the most effective drugs for raising levels of "good" cholesterol and lowering levels of "bad" cholesterol and other lipids (fats), thereby reducing the risk of heart attack. However, patients often stop taking the drug due to one specific side effect, flushing of the skin t ...
read more Wed May 2009
CVS Caremark Study Documents Changes In Prescription Drug Use To Treat High Blood Pressure, High Cholesterol And Diabetes In Children And Adolescents
Categorie : CholesterolA study by CVS Caremark (NYSE: CVS) published in the April 2009 issue of Archives of Pediatrics and Adolescent Medicine, found that over a two-and-a-half year period ending in June 2007, the use of medications to treat high blood pressure, high cholesterol and diabetes among children increased 15.2 ...
read more Wed May 2009
New Study Demonstrates Improvements In LDL-Cholesterol On Top Of Statin Therapy With HEP-40, A Novel Natural Product
Categorie : CholesterolDiversified Natural Products, Inc. reported results of a new study presented this week at the 58th annual Scientific Sessions of the American College of Cardiology, demonstrating that the addition of HEP-40 (enzymatically hydrolyzed polysaccharide with a molecular weight of 40 kiloDaltons) to statin ...
read more Wed May 2009
Decreasing Markers Of Inflammation Is As Important For Statin Action As Decreasing Ldl Cholesterol (Jupiter Study)
Categorie : CholesterolA follow-up study on the JUPITER* trial has revealed that a key component of the action of statins is reduction of high sensitivity c-reactive protein (hsCRP), a marker of inflammation, as well as reducing levels of bad cholesterol. The findings are published in an Article published Online First and ...
read more Wed May 2009
New Survey Of GPs Reveals Support For Continued Focus On Cholesterol-lowering In QOF1, UK
Categorie : CholesterolThe results of a new survey of 400 UK healthcare professionals, conducted by TNS Healthcare UK and sponsored by Merck Sharp & Dohme Limited and Schering-Plough Limited, reveal that the majority of GPs surveyed (82% of the 100 GPs) believe that the cholesterol indicator (CHD 08) should remain a prio ...
read more Wed May 2009
Cholesterol-Busting Bug With A Taste For Waste
Categorie : CholesterolA novel species of bacteria with cholesterol-busting properties has been discovered by scientists at the Universidad Complutense de Madrid, Spain. Dr Oliver Drzyzga and colleagues isolated the new bug, called Gordonia cholesterolivorans, from sewage sludge. Their findings are reported in the current ...
read more Wed May 2009
